 diseased vessel and end organ, and anticipated morbidity and mortality risk of combined
repair. Prophylactic treatment of associated asymptomatic renal or mesenteric artery disease cannot be justiﬁed.354,355 The exception may be the patient presenting
with high-grade stenosis of the SMA and a meandering
mesenteric artery that is based off of a large IMA,
which will be sacriﬁced during the course of treatment.
A decision